Efficacy of adjuvant weight loss medication after bariatric surgery Zubaidah Nor Hanipah, M.D., Elie C. Nasr, B.A., Emre Bucak, M.D., Philip R. Schauer, M.D., Ali Aminian, M.D., Stacy A. Brethauer, M.D., Derrick Cetin, D.O. Surgery for Obesity and Related Diseases Volume 14, Issue 1, Pages 93-98 (January 2018) DOI: 10.1016/j.soard.2017.10.002 Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions
Fig. 1 (A) Mean weight. (B) Mean body mass index (BMI). LAGB = laparoscopic adjustable gastric band; RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy. Surgery for Obesity and Related Diseases 2018 14, 93-98DOI: (10.1016/j.soard.2017.10.002) Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions
Fig. 2 (A) Total weight loss (TWL)>5% at 3 months after adjuvant pharmacotherapy. (B) TWL>5% at 12 months after adjuvant pharmacotherapy. (C) TWL>10% at 3 months after adjuvant pharmacotherapy. (D) TWL>10% at 12 months after adjuvant pharmacotherapy. LAGB = laparoscopic adjustable gastric band; RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy. Surgery for Obesity and Related Diseases 2018 14, 93-98DOI: (10.1016/j.soard.2017.10.002) Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions